Physician profile
Marie Bailey
NPI 1316985294
$911.60
in general payments reported to CMS, 2019-2025
18 companies · $151 in 2025
The $151 reported for 2025 was less than what a typical Gastroenterology (Internal Medicine) provider received nationally (typical 2025 total: $636).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $48.18 · 2020: $34.54 · 2021: $170 · 2022: $49.00 · 2023: $250 · 2024: $209 · 2025: $151.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $610.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $609.55 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Braintree Laboratories, INC. | $119.13 | 2021 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $110.67 | 2019-2025 | Xifaxan |
| Celgene Corporation | $100.74 | 2022-2024 | Zeposia |
| Ironwood Pharmaceuticals, INC | $81.90 | 2023 | Linzess |
| Pfizer INC. | $72.39 | 2020-2025 | |
| Janssen Biotech, INC. | $63.32 | 2023 | Stelara, Remicade, Simponi Aria |
| Sanofi Pasteur INC. | $55.15 | 2023 | |
| Takeda Pharmaceuticals U.S.A., INC. | $49.88 | 2025 | Entyvio |
| Regeneron Healthcare Solutions, INC. | $48.26 | 2024 | Dupixent |
| Abbvie INC. | $38.96 | 2021 | |
| Boston Scientific Corporation | $35.85 | 2024 | Compliance Endokit, Endoarmor |
| Biofire Diagnostics, LLC | $33.19 | 2019 | |
| Genzyme Corporation | $23.00 | 2024 | |
| Lilly USA, LLC | $19.68 | 2025 | Omvoh |
| Intercept Pharmaceuticals, INC. | $17.66 | 2020 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Phathom Pharmaceuticals, INC. | $14.85 | 2025 | Voquezna |
| Gilead Sciences, INC. | $14.73 | 2022 | |
| Medtronic, INC. | $12.24 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Marie Bailey listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.